- Home
- SONN vs GCTK Comparison
SONN vs GCTK Comparison
Compare SONN & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- GCTK
- Stock Information
- Founded
- SONN N/A
- GCTK 2001
- Country
- SONN United States
- GCTK United States
- Employees
- SONN N/A
- GCTK N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- GCTK Medical/Dental Instruments
- Sector
- SONN Health Care
- GCTK Health Care
- Exchange
- SONN Nasdaq
- GCTK Nasdaq
- Market Cap
- SONN 3.8M
- GCTK 4.1M
- IPO Year
- SONN N/A
- GCTK N/A
- Fundamental
- Price
- SONN $1.50
- GCTK $6.29
- Analyst Decision
- SONN Strong Buy
- GCTK
- Analyst Count
- SONN 1
- GCTK 0
- Target Price
- SONN $20.00
- GCTK N/A
- AVG Volume (30 Days)
- SONN 50.9K
- GCTK 1.6M
- Earning Date
- SONN 08-13-2025
- GCTK 08-12-2025
- Dividend Yield
- SONN N/A
- GCTK N/A
- EPS Growth
- SONN N/A
- GCTK N/A
- EPS
- SONN N/A
- GCTK N/A
- Revenue
- SONN $1,000,000.00
- GCTK N/A
- Revenue This Year
- SONN $5,376.22
- GCTK N/A
- Revenue Next Year
- SONN N/A
- GCTK N/A
- P/E Ratio
- SONN N/A
- GCTK N/A
- Revenue Growth
- SONN 978.39
- GCTK N/A
- 52 Week Low
- SONN $1.08
- GCTK $5.16
- 52 Week High
- SONN $10.02
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- SONN 70.61
- GCTK 43.40
- Support Level
- SONN $1.10
- GCTK $5.71
- Resistance Level
- SONN $1.17
- GCTK $7.25
- Average True Range (ATR)
- SONN 0.09
- GCTK 1.45
- MACD
- SONN 0.03
- GCTK 0.07
- Stochastic Oscillator
- SONN 80.37
- GCTK 10.47
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.